Cargando…

In vitro and in vivo effects of geranylgeranyltransferase I inhibitor P61A6 on non-small cell lung cancer cells

BACKGROUND: Lung cancer is the leading cause of cancer-related mortality. Therapies against non-small cell lung cancer (NSCLC) are particularly needed, as this type of cancer is relatively insensitive to chemotherapy and radiation therapy. We recently identified GGTI compounds that are designed to b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zimonjic, Drazen B, Chan, Lai N, Tripathi, Veenu, Lu, Jie, Kwon, Ohyun, Popescu, Nicholas C, Lowy, Douglas R, Tamanoi, Fuyuhiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3639152/ https://www.ncbi.nlm.nih.gov/pubmed/23607551 http://dx.doi.org/10.1186/1471-2407-13-198

Ejemplares similares

Identification and Characterization of Mechanism of Action of P61-E7, a Novel Phosphine Catalysis-Based Inhibitor of Geranylgeranyltransferase-I
por: Chan, Lai N., et al.
Publicado: (2011)

Nanoformulation of Geranylgeranyltransferase-I Inhibitors for Cancer Therapy: Liposomal Encapsulation and pH-Dependent Delivery to Cancer Cells
por: Lu, Jie, et al.
Publicado: (2015)

DLC1 suppresses NF-κB activity in prostate cancer cells due to its stabilizing effect on adherens junctions
por: Tripathi, Veenu, et al.
Publicado: (2014)

Acquired genetic and functional alterations associated with transforming growth factor β type I resistance in Hep3B human hepatocellular carcinoma cell line
por: Zimonjic, Drazen B, et al.
Publicado: (2009)

Geranylgeranyltransferase I is essential for dendritic development of cerebellar Purkinje cells
por: Wu, Kong-Yan, et al.
Publicado: (2010)

Synergistic Effect of Geranylgeranyltransferase Inhibitor, GGTI, and Docetaxel on the Growth of Prostate Cancer Cells
por: Han, Bin, et al.
Publicado: (2012)

Role of DLC1 tumor suppressor gene and MYC oncogene in pathogenesis of human hepatocellular carcinoma: Potential prospects for combined targeted therapeutics
por: ZIMONJIC, DRAZEN B., et al.
Publicado: (2012)

DLC-1:a Rho GTPase-activating protein and tumour suppressor
por: Durkin, Marian E, et al.
Publicado: (2007)

Inhibition of protein farnesylation enhances the chemotherapeutic efficacy of the novel geranylgeranyltransferase inhibitor BAL9611 in human colon cancer cells
por: Paolo, A Di, et al.
Publicado: (2001)

GGTase3 is a Newly Identified Geranylgeranyltransferase Targeting a Ubiquitin Ligase
por: Kuchay, Shafi, et al.
Publicado: (2019)

Rab Geranylgeranyltransferase Subunit Beta as a Potential Indicator to Assess the Progression of Amyotrophic Lateral Sclerosis
por: Yang, Jing, et al.
Publicado: (2023)

Molecular and Pharmacological Characterization of the Interaction between Human Geranylgeranyltransferase Type I and Ras-Related Protein Rap1B
por: Hinz, Sonja, et al.
Publicado: (2021)

Recent Development to Explore the Use of Biodegradable Periodic Mesoporous Organosilica (BPMO) Nanomaterials for Cancer Therapy
por: Chinnathambi, Shanmugavel, et al.
Publicado: (2020)

Preface
por: Chaiyen, Pimchai, et al.
Publicado: (2020)

Dissecting the roles of DR4, DR5 and c-FLIP in the regulation of Geranylgeranyltransferase I inhibition-mediated augmentation of TRAIL-induced apoptosis
por: Chen, Shuzhen, et al.
Publicado: (2010)

Fission yeast arrestin-related trafficking adaptor, Arn1/Any1, is ubiquitinated by Pub1 E3 ligase and regulates endocytosis of Cat1 amino acid transporter
por: Nakashima, Akio, et al.
Publicado: (2014)

Tumor Accumulation of PIP-Based KRAS Inhibitor KR12 Evaluated by the Use of a Simple, Versatile Chicken Egg Tumor Model
por: Higashi, Yuya, et al.
Publicado: (2022)

PAK1 Kinase Promotes Cell Motility and Invasiveness through CRK-II Serine Phosphorylation in Non-Small Cell Lung Cancer Cells
por: Rettig, Matthew, et al.
Publicado: (2012)

The hedgehog inhibitor GANT61 sensitizes prostate cancer cells to ionizing radiation both in vitro and in vivo
por: Gonnissen, Annelies, et al.
Publicado: (2016)

An oncogenic mutant of RHEB, RHEB Y35N, exhibits an altered interaction with BRAF resulting in cancer transformation
por: Heard, Jeffrey J., et al.
Publicado: (2018)

Patient Derived Chicken Egg Tumor Model (PDcE Model): Current Status and Critical Issues
por: Komatsu, Aoi, et al.
Publicado: (2019)

Significance of KRAS/PAK1/Crk pathway in non-small cell lung cancer oncogenesis
por: Mortazavi, Fariborz, et al.
Publicado: (2015)

Significance of filamin A in mTORC2 function in glioblastoma
por: Chantaravisoot, Naphat, et al.
Publicado: (2015)

Studies on the Exposure of Gadolinium Containing Nanoparticles with Monochromatic X-rays Drive Advances in Radiation Therapy
por: Tamanoi, Fuyuhiko, et al.
Publicado: (2020)

Analysis of cell–nanoparticle interactions and imaging of in vitro labeled cells showing barcorded endosomes using fluorescent thiol-organosilica nanoparticles surface-functionalized with polyethyleneimine
por: Nakamura, Michihiro, et al.
Publicado: (2022)

mTORC2 interactome and localization determine aggressiveness of high-grade glioma cells through association with gelsolin
por: Chantaravisoot, Naphat, et al.
Publicado: (2023)

GANT61, a GLI inhibitor, sensitizes glioma cells to the temozolomide treatment
por: Li, Jianlong, et al.
Publicado: (2016)

In vitro and in vivo inhibition of breast cancer cell growth by targeting the Hedgehog/GLI pathway with SMO (GDC-0449) or GLI (GANT-61) inhibitors
por: Benvenuto, Monica, et al.
Publicado: (2016)

Chaperone-Mediated Sec61 Channel Gating during ER Import of Small Precursor Proteins Overcomes Sec61 Inhibitor-Reinforced Energy Barrier
por: Haßdenteufel, Sarah, et al.
Publicado: (2018)

Measurement of average decoding rates of the 61 sense codons in vivo
por: Gardin, Justin, et al.
Publicado: (2014)

Designing Mesoporous Silica Nanoparticles to Overcome Biological Barriers by Incorporating Targeting and Endosomal Escape
por: Gisbert-Garzarán, Miguel, et al.
Publicado: (2021)

Organosilica nanoparticles containing sodium borocaptate (BSH) provide new prospects for boron neutron capture therapy (BNCT): efficient cellular uptake and enhanced BNCT efficacy
por: Laird, Mathilde, et al.
Publicado: (2023)

Inhibition of autophagy potentiates the efficacy of Gli inhibitor GANT-61 in MYCN-amplified neuroblastoma cells
por: Wang, Jing, et al.
Publicado: (2014)

DLC1: a tumor suppressor that regulates Rho signaling
por: Tripathi, Brajendra K., et al.
Publicado: (2017)

Operation des lignes F61, F61S, F61N ET T8
por: Ferrando, O.
Publicado: (1999)

Differential Requirement of CAAX-mediated Posttranslational Processing for Rheb Localization and Signaling
por: Hanker, Ariella B., et al.
Publicado: (2009)

Frequent downregulation and loss of WWOX gene expression in human hepatocellular carcinoma
por: Park, S-W, et al.
Publicado: (2004)

Anti‐cancer stem cell activity of a hedgehog inhibitor GANT61 in estrogen receptor‐positive breast cancer cells
por: Kurebayashi, Junichi, et al.
Publicado: (2017)

Cysteine-rich 61 (Cyr61) upregulated in pulmonary arterial hypertension promotes the proliferation of pulmonary artery smooth muscle cells
por: Gao, Lan, et al.
Publicado: (2017)

BAY61-3606 Affects the Viability of Colon Cancer Cells in a Genotype-Directed Manner
por: Lau, Ken S., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_emt8fhofh1c10ktq4fm1dg1iob